Fountain Valley, CANCT07420283Now EnrollingIRB Ready

Opioid Use Disorder Clinical Trial in Fountain Valley, CA

Access cutting-edge opioid use disorder treatment through this clinical trial at a research site in Fountain Valley. Study-provided care at no cost to qualified participants.

Sponsored by Eli Lilly and Company

Quick Self-Assessment

See if you qualify for this Fountain Valley location

Preparing your pre-screening questions…

Expert Care in Fountain Valley

Access opioid use disorder specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related opioid use disorder treatment provided free

Apply for This Fountain Valley Location

Check if you qualify for this opioid use disorder clinical trial in Fountain Valley, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Fountain Valley

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Fountain Valley site if eligible
  4. 4Begin participation

About This Opioid Use Disorder Study in Fountain Valley

The purpose of this study is to see if brenipatide, when compared to placebo, is safe and effective for participants with opioid use disorder, when used with buprenorphine with or without naloxone. The maximum potential duration of study participation for a participant in Part A is approximately 144 weeks, maximum potential duration of study participation for a participant in Part B is approximately 116 weeks. The actual duration will vary for each participant depending on the time of enrollment and the overall rate of study enrollment.

Sponsor: Eli Lilly and Company

Who Can Participate

Inclusion Criteria

Have a current mild, moderate or severe opioid use disorder (OUD)
Are reliable and willing to make themselves available for the duration of the study (for example, are not incarcerated, not homeless) and attend required study visits, and are willing and able to follow study procedures as required, such as
self-inject study intervention Note: Participants who are not able to perform the injections must have the assistance of a support person trained to administer the study intervention
store and use the provided study intervention as directed
maintain electronic or paper study diaries, as applicable, and
complete the required questionnaires
Are intermittently using non-legal, non-prescribed opioids
Are taking buprenorphine for treatment on OUD

Exclusion Criteria

Evidence of other substance use disorder(s) within 180 days of screening, except the following are permitted: any level tobacco use disorder, mild-to-moderate alcohol or mild-to-moderate cannabis use disorder Note: any level of caffeine use is allowed
Are actively suicidal or deemed a significant risk for suicide
Have a history of advanced liver disease (including advanced liver fibrosis or cirrhosis or alcohol-associated hepatitis based on either prior liver histology or imaging studies, such as transient elastography, ultrasound, computed tomography (CT) and magnetic resonance imaging (MRI), or Enhanced Liver Fibrosis score
Have participated in a clinical study and received active treatment, or unknown if they received active treatment, within 90 days or 5 half-lives (whichever is longer) before screening
Had opioid overdose in past 6 months prior to screening
Have a lifetime history or current diagnosis of the following:
schizophrenia or other psychotic disorder
bipolar disorder
borderline personality disorder
any eating disorder
Have type 1 diabetes mellitus, or a history of ketoacidosis, or hyperosmolar state, or coma

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Fountain Valley?

Yes, this clinical trial (NCT07420283) has an active research site in Fountain Valley, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Opioid Use Disorder Treatment Options in Fountain Valley, CA

If you're searching for opioid use disorder treatment options in Fountain Valley, CA, this clinical trial (NCT07420283) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Fountain Valley research site is actively enrolling participants for this clinical trial. You'll receive care from experienced opioid use disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all opioid use disorder clinical trials near you to find additional studies recruiting in your area.

More Substance Use Disorder Trials in Fountain Valley, CA

See all substance use disorder clinical trials recruiting in Fountain Valley — not just this study.

Browse Substance Use Disorder Trials in Fountain Valley →

Browse More Trials by Condition

Substance Use Disorder TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Fountain Valley?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Fountain Valley, CA